Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on CT
KCT0010490Phase 4Not yet recruiting
- Sponsor
- Cardiovascular Research Foundation
- Start
- Jul 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin, ulinastatin in atherosclerosis, coronary arteriosclerosis, sponsored by Cardiovascular Research Foundation. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
aspirinulinastatin
03
Conditions
atherosclerosiscoronary arteriosclerosis
Beyond the preview
Go deeper on KCT0010490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0010490.